Publications by authors named "Sandor Fritsch"

Claim this Profile
R
Response to the Letter to the Editor Regarding "Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials".
Daniel Suez, Mark Stein, Sudhir Gupta, Iftikhar Hussain, Isaac Melamed, Sandor Fritsch

J Clin Immunol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 trial of IV immunoglobulin for Alzheimer disease.
Norman R Relkin, Ronald G Thomas, Robert A Rissman, James B Brewer, Michael S Rafii, Sandor Fritsch

Neurology· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Pharmacokinetics of a Novel Human Immune Globulin Subcutaneous, 20 % in Patients with Primary Immunodeficiency Diseases in North America.
Daniel Suez, Mark Stein, Sudhir Gupta, Iftikhar Hussain, Isaac Melamed, Sandor Fritsch

J Clin Immunol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of protein C concentrate to treat purpura fulminans and thromboembolic events in severe congenital protein C deficiency.
Marilyn J Manco-Johnson, Lisa Bomgaars, Joseph Palascak, Amy Shapiro, John Geil, Sandor Fritsch

Thromb Haemost· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demonstration of safety of intravenous immunoglobulin in geriatric patients in a long-term, placebo-controlled study of Alzheimer's disease.
David Gelmont, Ronald G Thomas, Jonathan Britt, Jacqueline A Dyck-Jones, Jennifer Doralt, Sandor Fritsch

Alzheimers Dement (N Y)· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease.
Joan C Gill, Giancarlo Castaman, Jerzy Windyga, Peter Kouides, Margaret Ragni, Sandor Fritsch

Blood· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II randomized double-blind study of the safety and immunogenicity of a nonadjuvanted vero cell culture-derived whole-virus H9N2 influenza vaccine in healthy adults.
Gerald Aichinger, Barbara Grohmann-Izay, Maikel V W van der Velden, Sandor Fritsch, Manuela Koska

Clin Vaccine Immunol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population.
Maikel V W van der Velden, Richard Fritz, Eva Maria Pöllabauer, Daniel Portsmouth, M Keith Howard, Sandor Fritsch

J Infect Dis· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.
Nina Wressnigg, Eva-Maria Pöllabauer, Gerald Aichinger, Daniel Portsmouth, Alexandra Löw-Baselli, Sandor Fritsch

Lancet Infect Dis· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C®) in infants.
Eva-Maria Poellabauer, Borislava G Pavlova, Sandor Fritsch, Julia Singer, Christian Neubauer

Vaccine· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory.
Alexandra Loew-Baselli, Borislava G Pavlova, Sandor Fritsch, Eva Maria Poellabauer, Wolfgang Draxler

Vaccine· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming.
Maikel V W van der Velden, Gerald Aichinger, Eva Maria Pöllabauer, Alexandra Löw-Baselli, Sandor Fritsch

Vaccine· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical development of a Vero cell culture-derived seasonal influenza vaccine.
Hartmut J Ehrlich, Gregory Berezuk, Sandor Fritsch, Gerald Aichinger, Julia Singer

Vaccine· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
Hartmut J Ehrlich, Markus Müller, Herwig Kollaritsch, Fritz Pinl, Bernhard Schmitt, Sandor Fritsch

Vaccine· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.
Roman Prymula, Eva Maria Pöllabauer, Borislava G Pavlova, Alexandra Löw-Baselli, Sandor Fritsch

Hum Vaccin Immunother· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individuals.
Hartmut J Ehrlich, Julia Singer, Gregory Berezuk, Sandor Fritsch, Gerald Aichinger

Clin Infect Dis· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight.
Sven Björkman, MyungShin Oh, Gerald Spotts, Phillip Schroth, Sandor Fritsch

Blood· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine.
Paul A Tambyah, Annelies Wilder-Smith, Borislava G Pavlova, P Noel Barrett, Helen M L Oh, Sandor Fritsch

Vaccine· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trial.
Gerald Aichinger, Hartmut J Ehrlich, John G Aaskov, Sandor Fritsch, Christiane Thomasser

Vaccine· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.
Alexandra Loew-Baselli, Eva Maria Poellabauer, Borislava G Pavlova, Sandor Fritsch, Clair Firth

Vaccine· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial.
P Noel Barrett, Gregory Berezuk, Sandor Fritsch, Gerald Aichinger, Mary Kate Hart

Lancet· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of immunogenicity and safety between two paediatric TBE vaccines.
Eva Maria Pöllabauer, Borislava G Pavlova, Alexandra Löw-Baselli, Sandor Fritsch, Roman Prymula

Vaccine· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine.
Eva Maria Pöllabauer, Sandor Fritsch, Borislava G Pavlova, Alexandra Löw-Baselli, Clair Firth

Vaccine· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses.
Hartmut J Ehrlich, Markus Müller, Sandor Fritsch, Markus Zeitlinger, Greg Berezuk

J Infect Dis· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.
Alexandra Loew-Baselli, Eva-Maria Poellabauer, Borislava G Pavlova, Sandor Fritsch, Manuela Koska

Hum Vaccin· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis